The Antibody Society

the official website of the antibody society

An international non-profit supporting antibody-related research and development.

  • LOG IN
  • BECOME A MEMBER
  • About Us
    • Our Team
      • Directors and Officers
      • Our Staff
      • Our Committees
    • Sponsors & Partners
  • Events Calendar
    • Current Events
  • AIRR Community
    • AIRR Community News
    • AIRR Community Newsletter
    • AIRR Community Seminar Series
    • AIRR Community Meetings
      • Zooming into the Community III
      • AIRR Community Meeting VII – Learnings and Perspectives
      • AIRR Community Special Event 2023  – Zooming in to the Community II
      • AIRR Community Meeting VI: “Exploring New Frontiers”
      • AIRR Community Meeting V: “Zooming in to the AIRR Community”
      • AIRR Community Meeting V Pre-Meetings
        • AIRR-seq in the Pandemic
        • AIRR-seq Biological Standards and Workflows
      • AIRR Community Special Event: “Response to COVID-19”
      • AIRR Community Meeting IV: “Bridging the Gaps”
      • AIRR Community Meeting III
        • Day 1
        • Day 2
        • Day 3
        • Day 4
      • AIRR Community Meeting II
      • AIRR Community Meeting I
    • On AIRR – An AIRR Community Podcast
    • AIRR Data Commons
    • AIRR-C Germline Database Resources
    • AIRR Community Publications
    • AIRR Community Working Groups
      • Biological Resources Working Group
      • Common Repository Working Group
      • Diagnostics Working Group
      • Germline Database Working Group
      • Legal and Ethics Working Group
      • Software Working Group
      • Standards Working Group
    • AIRR Community Sub-Committees
      • Communications Sub-Committee
      • Executive Sub-Committee
      • Inferred Allele Review Committee
      • Meetings Sub-Committee
      • Strategic Planning Sub-Committee
    • AIRR Community Webinar Series
    • AIRR Community Calendar
    • AIRR Community Resources
  • Members only
    • Login
    • Note to members
    • Member discount codes
    • 2025 Calendar of Events
    • James S. Huston Antibody Science Talent Award
      • 2025 James S. Huston Antibody Science Talent Award Recipient
      • 2024 James S. Huston Antibody Science Talent Award Recipient
      • 2023 James S. Huston Antibody Science Talent Award Recipient
      • 2022 James S. Huston Antibody Science Talent Award Recipient
      • 2021 James S. Huston Antibody Science Talent Award Recipient
      • 2020 James S. Huston Antibody Science Talent Award Recipient
      • Huston Award submission guidelines
    • Research Competitions
      • The Antibody Society’s Research Competition Winners
    • Science Writing Competition
      • Science Writing Competition Winners
    • Imaging Competition
      • Imaging Calendar Competition winners
        • The Antibody Society 2025 Calendar
        • The Antibody Society 2024 Calendar
    • Antibodies in early-stage studies
    • Presentations
  • Upcoming meetings in 2025
  • Web Resources
    • Society Publications
    • Antibody News
    • Antibody News Podcast
    • Antibody therapeutics approved or in regulatory review in the EU or US
      • Antibody therapeutics product data
    • Antibodies in late-stage clinical studies
    • Research Resources
    • Education Resources
  • Career Center
    • Career Shorts
  • Learning Center
    • Upcoming Webinars in 2025
    • The Antibody Series Lectures 2025
    • Antibody Discovery & Development
    • Adaptive Immune Receptor Repertoires
    • Antibodies to Watch
    • Commercializing Antibody Therapeutics
    • Antibody Validation
      • 4th International Antibody Validation Meeting, Sep 2023
    • Snakebite antivenoms: Global challenges and progress toward recombinant antibody therapeutics
You are here: Home / International non-proprietary names / How antibody USAN and INN sing a different tune

How antibody USAN and INN sing a different tune

August 17, 2017 by The Antibody Society

We recently reported about the new World Health Organization (WHO) naming scheme for antibody therapeutics which resulted in deleting the source infix in international nonproprietary names (INN) (Parren, Carter & Plückthun, MAbs 2017 9:898-906). The changes implemented remove critical ambiguities in antibody naming going forward.

The WHO has now released the full executive summary of the 64th Consultation on International Nonproprietary Names for Pharmaceutical Substances at which the decision to remove the source infix was taken. The summary is in full agreement with the information previously provided in our perspective.  Notably, the new scheme will change the sounds of antibody names that have become so familiar to us (see Table 1). This diversification is in fact quite important as distinct names are thought to further reduce the potential for medication errors as more therapeutic antibodies make it to the market.

Alignment of INNs with United States Adopted Names (USAN) is essential since (approved) antibody therapeutics will usually carry both an INN and a USAN. We are therefore very pleased to report that the USAN Council has agreed to implement the same naming scheme. Eliminating the source infix also ends an important disagreement between the USAN Council and WHO on how the source infix should be defined and assigned (also see Parren et al. Mabs 2017 for more information). Importantly, it is noted that no changes to previously assigned USAN names are contemplated. Similarly, WHO notes that substituting previously assigned INNs requires extraordinary circumstances such as medication, prescription or distribution errors that occur due to name similarities, also indicating that existing INN will unlikely be changed.

Notably, the WHO stresses the importance of careful dissemination of information on the new scheme and highlights the role of The Antibody Society. Consequently we will continue to update you via this channel as new information becomes available.

Like this post, but not a member? Please join!

Membership is free for students and employees of the Society’s corporate sponsors.

Filed Under: International non-proprietary names Tagged With: International nonproprietary names, United States Adopted Names, World Health Organization

Share this post

  • LinkedIn
  • Home
  • Privacy & Terms of Use
  • About
  • Directors and Officers
  • Advisors
  • Sponsors & Partners Old
  • Mission & Activities
  • Join the Society
  • Membership Levels
  • Members only
  • Login
  • Antibody therapeutics approved or in regulatory review in the EU or US
  • Meeting reports
  • Presentations
  • Contact

©2015 - scicomvisuals